​​Serial entrepreneur Dr Srinubabu buys Canada’s health informatics company PULSUS

Pulsus focus will be to lead Pharmacovigilance works including collection, archival and monitoring of Individual Case Study Reports, studies in the global market. To increase headcount from 500 to 2000 by 2018

Download PDF

Hyderabad: Indian serial entrepreneur Dr Srinubabu has acquired Canada based scientific medical informatics Pulsus Group Inc, foraying into big scientific, medical informatics market worldwide for an undisclosed amount. He also announced PULSUS will expand in India with 2 new centers, Chennai and Gurgaon in next few months and these 2 centers will be an addition to Hyderabad center.

“PULSUS is committed to building the domestic scientific and medical Informatics market supported by a team of 500 people with a target to grow the team to 2000 by early next year. This is a 100% acquisition through a combination of cash and equity.” Dr Srinubabu stated who will spearhead the venture as CEO.

“In recent years, cities like Chennai and Gurgaon has become increasingly important as a center for science and research, as can be seen in the growing number of universities and companies with R & D departments. PULSUS is young in India; our aim is to become the authentic healthcare informatics source for university libraries, research institutes, students and academics, as well as for corporate R & D departments. Dr Srinu said.

Established in the year 1984, Pulsus initially focused on American region and presently it is expanding to healthcare informatics platform to the medical and pharma professionals throughout Europe, America, Asia, Australia and all other continents. Since its inception, Pulsus has received the endorsements of the medical associations and industries of the international reputation.

Stating about PULSUS activities Dr Srinu said “In every city we will work with partners in the region to develop publications of worldwide interest and enhance reputation to our high scientific standards. These offices will be serving all of its clients and potential clients for all related products and services. Our target is to open our center in New Delhi early 2018.

Dr Srinu’s most notable venture includes Omics International – world’s leading open access journal with an estimated 50 millions users and growing. Omics owns 1,000 open-access journal titles that post 50,000 articles annually in fields including medicine, technology, and engineering. It’s also built a robust conference division that will hold about 3,000 events worldwide this year. He has also invested in digital media, education among other sectors.

A 2015 study in the journal BMC Medicine estimated revenue generated by the open-access journals market with $344 million for open access publishers and the $10.5 billion that traditional journals make from global subscriptions.

Headquartered at Singapore, PULSUS group has its offices in London (UK), Ontario, (Canada) and Hyderabad (India). PULSUS work is endorsed by the medical associations and scientific societies.